Megan Doyle

Megan Doyle, PhD, currently serves as SVP and Medical Group Leader at MERGE, overseeing scientific and medical strategy for various accounts since February 2020. Previously held positions include Senior Director of Scientific Strategy at Envision Communications and Scientific Director at Razorfish Health. Megan Doyle has extensive experience in medical science strategy, focusing on relationship development, KOL recruitment, and content creation across multiple therapeutic areas, including oncology and cardiovascular medicine. Earlier roles include Associate Scientific Director at Discovery USA and Scientific Content Specialist at Cadent Medical Communications. Megan Doyle earned a PhD in Biomedical Engineering from the University of Virginia and a BS in Chemical Engineering from The University of Texas at Austin.